Fig. 1: Overall survival and cumulative incidence of relapse by pre-transplant MRD status in patients who received reduced intensity vs. myeloablative conditioning.

a OS in MRD+ and MRD− patients who received MAC. b OS in MRD+ and MRD− patients who received RIC. c CIR in MRD+ and MRD− patients who received MAC. d CIR in MRD+ and MRD− patients who received RIC.